Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ARREST PNEUMONIA
NCT04193878Phase 3Terminated
- Sponsor
- Stanford University
- Start
- Jun 2020
- Primary completion
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of budesonide and formoterol in pneumonia and coronavirus disease 2019 (COVID-19) (2 arms), sponsored by Stanford University. Primary endpoint: Acute Respiratory Failure at 7 days. Started Jun 2020; status: terminated.
02
Drugs
budesonideformoterol
03
Conditions
pneumoniacoronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04193878.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04193878.